KATHLEEN SALVATORE: Open Payments
NPI 1053408229 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 37 payments from 8 companies in 2025. Trend: 2023 $1,110 · 2024 $1,678 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $305 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $231 |
| Alkermes, Inc. | 4 | $188 |
| Axsome Therapeutics, Inc. | 2 | $143 |
| Teva Pharmaceuticals USA, Inc. | 2 | $139 |
| Lundbeck LLC | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, Auvelity, AUSTEDO XR, LYBALVI, REXULTI, TRINTELLIX, ARISTADA.
Industry payments across TX — which companies pay providers there.
